Canada's Ebola vaccine timeline

2002

• Vaccine developed at the Agency's National Microbiology Laboratory
• Patent protection

2002-2012

• Experiments done on animals to test effectiveness

2010

• Commercial license granted to NewLink Genetics

2013

• One lot, approximately 1500 vials, of Ebola vaccine manufactured for research and clinical trials

2014

• Canada donates vials of vaccine to the WHO
• Clinical trials begin in healthy people to test for safety
• 800 vials of the vaccine shipped to the WHO

2015

• Clinical trials on hundreds of healthy people to test for efficacy
• Manufacturing vials of vaccine for trials

And beyond

• Drug regulators like Health Canada will receive application to approve the vaccine
• Health Canada to review research data and approve if it deems it safe and effective
• Mass manufacturing begins